Inhibition of nitric oxide synthesis in wounds: Pharmacology and effect on accumulation of collagen in wounds in mice

European Journal of Surgery

Volumn 165, Issue 3, 1999, Pages 262-267

  Schäffer, Michael R ^b   Tantry, Udaya ^a   Thornton, Francis J ^a   Barbul, Adrian ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Aminoguanidine; Collagen; Mouse; N nitro L arginine methylester; NG L monomethyl arginine; Nitric oxide synthase; S methyl isothiouronium; Wound fluid; Wound healing

Indexed keywords

AMINOGUANIDINE; COLLAGEN; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POLYVINYL ALCOHOL SPONGE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN INCISION; TEACHING HOSPITAL; UNITED STATES; WOUND; WOUND HEALING;

ANALYSIS OF VARIANCE; ANIMALS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE; RANDOM ALLOCATION; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0032816826     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241599750007153     Document Type: Article

References (22)

1. 1. Albina JE, Mills CD, Barbul A, et al. Arginine metabolism in wounds. Am J Physiol 1988; 254: E459-467.
2. 2. Albina JE, Mills CD, Henry WL, Caldwell MD. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol 1990; 144: 3877-3880.
3. 3. Anggård E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199-1206.
4. 4. Beckermann KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER. Release of nitric oxide during the T-cell dependent pathway of macrophage activation. J Immunol 1993; 150: 888-895.
5. 5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
6. 6. Bulgrin JP, Shabani M, Chakravarthy D, Smith DJ. Nitric oxide synthesis is suppressed in steroid-impaired and diabetic wounds. Wounds 1995; 7: 48-57.
7. 7. Carter EA, Derojas-Walker T, Tamir S, Tannenbaum SR, Yu YM, Tompkins RG. Nitric oxide production is intensely and persistently increased in tissue by thermal injury. Biochem J 1994; 304: 201-204.
8. 8. Gardiner SM, Bennett T, Kemp PA, Palmer RMJ, Moncada S. Chronic oral ingestion of nitric oxide synthase inhibitors causes sustained, but reversible, hypertension in Brattleboro rats. In: Moncada S, Marletta MA, Hibbs JB Jr., Higgs EA, eds. The biology of nitric oxide - I. Physiological and clinical aspects. London: Portland Press, 1992: 127-128.
9. 9. Gilliam MB, Sherman MP, Griscavage JM, Ignarro LJ. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem 1993; 212: 359-365.
10. 15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
11. 11. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: A physiologic messenger. Ann Intern Med 1994; 120: 227-237.
12. 12. McDonnell SE, Kerr LD, Matrisian LM. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Moll Cell Biol 1990; 10: 4284-4293.
13. 13. McGeorge M, Sherif M, Smirk FH. Observations on the properties of S-methyl-iso-thiourea sulphate, with particular reference to the circulatory effects. J Physiol 1942; 100: 474-483.
14. 14. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-141.
15. 15. Narayanan K, Griffith OW. Synthesis of L-thiocitrulline, L-homocitrulline, and S-methyl-L-thiocitrulline: a new class of potent nitric oxide synthase inhibitors. J Med Chem 1994; 37: 885-887.
16. 16. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ. Matrix metalloproteinases. Br J Surg 1997; 84: 160-166.
17. 17. Schäffer MR, Efron PA, Thornton FJ, Klingel K, Gross SS, Barbul A. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997; 158: 2375-2381.
18. 18. Schäffer MR, Tantry U, Ahrendt GM, Wasserkrug HL, Barbul A. Acute protein-calorie malnutrition impairs wound healing: a possible role of decreased wound nitric oxide synthesis. J Am Coll Surg 1997; 184: 37-43.
19. 19. Schäffer MR, Tantry U, Barbul A. Sustained nitric oxide synthesis in wounds. J Surg Res 1997; 71: 25-31.
20. 20. Schäffer MR, Tantry U, Efron PA, Ahrendt GM, Wasserkrug HL, Barbul A. Diabetes-impaired wound healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. Surgery 1997; 121: 513-519.
21. 21. Witte MB, Schäffer MR, Barbul A. Phenotypic induction of nitric oxide is critical for synthetic function in wound fibroblasts. Surg Forum 1996; 47: 703-705.
22. 22. Woessner J. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961; 93: 440-447.